PO Box 2345, Beijing 100023, Chin World J Gstroenterol 2005;11(31):4838-4842 www.wjgnet.com World Journl of Gstroenterology ISSN 1007-9327 wjg@wjgnet.com ELSEVIER 2005 The WJG Press nd Elsevier Inc. All rights reserved. CLINICAL RESEARCH Sonogrphic ftty liver, overweight nd ischemic hert disese Yu-Cheng Lin, Huey-Ming Lo, Jong-Dr Chen Yu-Cheng Lin, Jong-Dr Chen, Deprtment of Fmily Medicine nd Center for Environmentl nd Occuptionl Medicine, Shin Kong Wu Ho-Su Memoril Hospitl, Tipei 111, Tiwn, Chin Huey-Ming Lo, Deprtment of Internl Medicine, Shin Kong Wu Ho-Su Memoril Hospitl; School of Medicine, Fu Jen Ctholic University, Tipei 111, Tiwn, Chin Correspondence to: Dr. Jong-Dr Chen, Deprtment of Fmily Medicine nd Center for Environmentl nd Occuptionl Medicine, Shin Kong Wu Ho-Su Memoril Hospitl, 95,Wen Chng Rod, Shih Lin, Tipei 111, Tiwn, Chin. jdrchen@ms28.hinet.net Telephone: +886-2-2833-2211-2626 Fx: +886-2-2838-9420 Received: 2004-12-01 Accepted: 2004-12-20 Abstrct AIM: To demonstrte the prevlence of sonogrphic ftty liver, overweight nd ischemic hert disese (IHD) mong the mle workers in Tiwn, nd to investigte the possible ssocition of these three fctors. METHODS: From July to September 2003, totl of 2 088 mle ircrft-mintennce workers ged from 22 to 65 yers (men 40.5) underwent n nnul helth exmintion, including nthropometricl evlution, blood pressure mesurement, personl medicl history ssessment, biochemicl blood nlysis, bdominl ultrsonogrphic exmintion nd digitl electrocrdiogrphy (ECG). The Student s t-test, χ 2 test nd multivrite logistic regression nlysis were utilized to evlute the reltionship between IHD nd slient risk fctors. RESULTS: The ll-over prevlence of overweight ws 41.4%, nd tht of ftty liver ws 29.5% (mild, moderte nd severe ftty liver being 14.5%, 11.3%, nd 3.7%, respectively); while the prevlence of ischemic chnges on ECG ws 17.1% in this study. The bnorml rtes for conventionl IHD risk fctors including hypertension, dyslipidemi, hyperglycemi nd overweight incresed in ccordnce with the severity of ftty liver. Overweight nd severity of ftty liver were independently ssocited with incresed risks for developing IHD. Overweight subjects hd 1.32-fold (95%CI: 1.01-1.73) incresed IHD risk. Prticipnts with mild, moderte, nd severe ftty liver hd 1.88-fold (95%CI: 1.37-2.6), 2.37-fold (95%CI: 1.66-3.37) nd 2.76-fold (95%CI: 1.62-4.72) incresed risk for developing IHD. The prevlence of ischemic ECG for the ftty liver-ffected subjects with or without overweight ws 30.1% nd 19.1%, while tht of overweight subjects free from ftty liver ws 14.4%. Compred to the subjects without ftty liver nor overweight, IHD risk for the three subgroups bove ws s follows: OR: 2.95 (95%CI: 2.31-4.09), OR: 1.60 (95%CI: 1.07-2.39) nd OR: 1.11 (95%CI: 0.78-1.56), respectively. CONCLUSION: The presence of ftty liver nd its severity should be crefully considered s independent risk fctors for IHD. Results of the study suggest the synergistic effect between ftty liver nd overweight for developing IHD. Abdominl sonogrphic exmintion my provide vluble informtion for IHD risk ssessment in ddition to limited report bout liver sttus, especilly for overweight mles. 2005 The WJG Press nd Elsevier Inc. All rights reserved. Key words: Ftty liver; Ischemic hert disese; Overweight; Mle; Middle-ged Lin YC, Lo HM, Chen JD. Sonogrphic ftty liver, overweight nd ischemic hert disese. World J Gstroenterol 2005; 11(31): 4838-4842 http://www.wjgnet.com/1007-9327/11/4838.sp INTRODUCTION Ftty chnge in the liver is closely ssocited with overweight sttus nd metbolic impirments such s hyperglycemi, nd dyslipidemi [1-3] which re lso regrded s fctors for therosclerosis [1,4,5] nd ischemic hert disese (IHD) [6-9]. However, the ssocition between ftty liver nd IHD is witing for epidemiologicl investigtion. Since resting electrocrdiogrm (ECG) nd bdominl sonogrphic exmintion re two routine, non-invsive helth exmintions used in medicl check-ups in Tiwn [10-15], we hd the opportunity to exmine the ssocition between ftty liver nd ischemic ECG chnges, the hllmrk of IHD nd strong predictor for crdic events [16-18]. The purpose of this study ws to evlute the reltionships between ftty liver nd IHD utilizing epidemic dt. Dt nlyses were controlled for conventionl risk fctors, especilly overweight. MATERIALS AND METHODS Subjects Records from totl of 2 088 mle ircrft mintennce workers who underwent periodic helth exmintion from July to September 2003. Methods The helth exmintions included nthropometricl evlution, mesurement of weight nd height, systolic nd distolic blood pressure. Definition of overweight ws BMI 25 kg/m 2, bsed on WHO criteri [19]. A questionnire bout personl medicl history, including lcohol (usge more thn once week: yes vs no) nd tobcco (current usge: yes vs no) consumption ws filled by the exminees.
Lin YC et l. Ftty liver reltes to ischemic hert disese 4839 Biochemicl blood tests were conducted by Hitchi utonlyzer model 7150 (Hitchi Corp, Tokyo, Jpn), including fsting plsm glucose, levels of triglyceride, nd totl, low, nd high-density lipoprotein (LDL, HDL) cholesterol. The definition of hypertension ws systolic blood pressure 18.7 kp or distolic blood pressure 12 kp. The cut points of hyperglycemi, hypocholesterolemi, hypercholesterolemi, nd hypertriglyceridemi were fsting sugr 6.1 mmol/l, HDL <1.0 mmol/l, totl cholesterol 5.2 mmol/l nd triglyceride 17.0 mmol/l. Abdominl ultrsonogrphic exmintions were performed using convex-type rel-time electronic scnners (Toshib SSA-340 with 3.75 MHz convex-type trnsducer) by three gstrointestinl specilists who were blind to the medicl history nd blood test results of the exminees. The definition of ultrsonic ftty liver ws bsed on comprtive ssessment of imge brightness reltive to the kidneys, in line with previously reported dignostic criteri [10,20-23]. Severity of ftty liver ws clssified ccording to the following modified scoring system [10,13,15,22,23] : brightness compred to kidneys (0-3), blurring of gll bldder wll (0-3), blurring of heptic veins (0-3), blurring of portl vein (0-3), fr gin ttenution (0-3). Severity ws defined s mild (totl scores of 2-6), moderte (7-10), nd severe (11-15) ftty liver. A digitl electrocrdiogrph recorder (Kenz Crdico 1207; Suzuken Co., Ltd 8, Higshi Kth-mchi, Higshiku Ngoy 461-8701, Jpn.) ws used for IHD ssessment. IHD ws defined bsed on evidence of resting ECG ischemic bnormlities, s expressed in computerized Minnesot code (1.1. -1.3., 4.1. -4.4., 5.1. -5.3. ) [12,16-18]. The Student s t nd χ 2 tests were used for nlyzing continuous vribles nd ctegoricl vribles, respectively. Multivrite logistic regression ws utilized to evlute the reltionship between IHD nd slient risk fctors. SAS softwre ws used for sttisticl nlysis (Version 8.0; SAS Institute, Cry, NC, USA). RESULTS After 63 cses whose dt were incomplete (e.g., biochemicl blood test, questionnire) were excluded, totl of 2 025 subjects were enrolled in the finl nlysis. The excluded subjects hd similr distribution of nthropometric mesurement nd biochemicl dt s subjects in finl nlysis. As shown in Tble 1, the ge for this smple popultion rnged from 22 to 63 yers (men, 40.5), the men vlue of BMI ws 24.6 kg/m 2. The over-ll prevlence of overweight ws 41.4%, while tht of ftty liver ws 29.5%. The prevlence of ischemic chnges in the resting ECG ws 17.1%. The mens nd stndrd devitions for serum blood sugr nd therogenic lipid profile were 5.7±1.1 mmol/l of fsting sugr, 5.1±0.9 mmol/l of totl cholesterol, 1.3±0.3 mmol/l of HDL cholesterol, 3.3±0.8 mmol/l of LDL cholesterol, nd 17.1±13.9 mmol/l of triglyceride. Tble 1 Bseline chrcteristics of middle-ged mle workers in Tiwn from periodic helth exmintion (men±sd, n = 2 025) Risk fctor Vlue Rnge Age (yr) 40.5±9.9 22.0-63.0 Height (cm) 169.6±6.3 150.1-191.1 Body weight (kg) 70.9±10.6 42.8-121.9 BMI (body mss index) (kg/m 2 ) 24.6±3.3 15.6-40.6 Systolic blood pressure (kp) 17.1±2.2 11.7-27.5 Distolic blood pressure (kp) 10.6±1.6 6.7-17.3 Fsting sugr (mmol/l) 5.7±1.1 3.0-24.5 Cholesterol totl (mmol/l) 5.1±0.9 2.6-9.3 Cholesterol HDL (mmol/l) 1.3±0.3 0.2-4.0 Cholesterol LDL (mmol/l) 3.3±0.8 1.2-7.1 Triglyceride (mmol/l) 17.1±13.9 3.1-171.1 ECG with ischemic chnges (n, %) 347 (17.1) Ftty liver (n, %) 597 (29.5) Overweight (n, %) 839 (41.4) Smoking (n, %) 702 (34.7) Alcohol use (n, %) 444 (21.9) Risk-fctor distribution mong subgroups strtified ccording to the severity of ftty liver, is presented in Tble 2. The prevlence of mild, moderte nd severe ftty liver ws 14.5%, 11.3%, nd 3.7%, respectively. The bnorml rtes for conventionl IHD risk fctor including hypertension, dyslipidemi, hyperglycemi nd overweight incresed in ccordnce with the severity of ftty liver (Figure 1). Tble 2 Assessment of risk fctors strtified ccording to severity of ftty liver (FL) n = 2 205 Risk fctors Non FL Mild FL Moderte FL Severe FL 1 428 (70.5%) 294 (14.5%) 228 (11.3%) 75 (3.7%) Age (yr) 39.8±9.9 41.8±9.9 42.7±9.4 c 42.6±9.5 e BMI (body mss index) (kg/m 2 ) 23.9±3.1 25.0±2.6 26.9±2.7 c 29.0±3.1 e Systolic blood pressure (kp) 16.9±2.2 17.2±2.1 17.5±2.2 c 18.3±2.6 e Distolic blood pressure (kp) 10.5±1.6 10.6±1.4 10.9±1.5 c 11.4±1.7 e Fsting sugr (mmol/l) 5.6±1.0 5.8±1.2 6.0±1.5 c 6.1±1.6 e Cholesterol totl (mmol/l) 5.0±0.9 5.2±0.9 5.3±0.9 c 5.3±0.9 e Cholesterol HDL (mmol/l) 1.3±0.3 1.2±0.2 1.1±0.2 c 1.1±0.2 e Cholesterol LDL (mmol/l) 3.3±0.8 3.5±0.8 3.4±0.8 c 3.4±0.9 e Triglyceride (mmol/l) 15.0±11.1 18.2±13.1 26.3±20.9 c 27.3±22.3 e ECG with ischemic chnges (n, %) 191 (13.4) 67 (22.8) 64 (28.1) c 25 (33.3) e Overweight (n, %) 457 (32.0) 143 (48.6) 170 (74.6) c 69 (92.0) e Smoking (n, %) 491 (34.4) 106 (36.1) 84 (36.8) 21 (28.0) Alcohol use (n, %) 304 (21.3) 73 (24.8) 54 (23.7) 13 (17.3) P<0.05 vs non FL group; c P<0.05 vs non FL group; e P<0.05 vs non FL group.
4840 ISSN 1007-9327 CN 14-1219/ R World J Gstroenterol August 21, 2005 Volume 11 Number 31 Abnorml rte (%) of risk fctors 100 90 80 70 60 50 40 30 20 10 0 Systolic hypertension Non-ftty liver Mild ftty liver Moderte ftty liver Severe ftty liver Distolic hypertension Hyperglycemi Hypo-HDL cholesterolemi Hyper-LDL cholesterolemi Hypercholesterolemi Hypertriglyceridemi IHD risk fctors strtified by the severity of ftty liver Overweight Figure 1 Abnorml rtes of IHD risk fctors for middle-ged mle workers in Tiwn. Multivrible nlysis nd odds rtios for IHD re summrized in Tble 3. Results showed tht overweight, incresed systolic blood pressure nd ftty liver severity were independently ssocited with IHD risk. Overweight subjects hd 1.32-fold (95%CI: 1.01-1.73) incresed IHD risk. Prticipnts with mild, moderte, nd severe ftty liver experienced 1.88-fold (95%CI: 1.37-2.60), 2.37-fold (95%CI: 1.66-3.37), nd 2.76-fold (95%CI: 1.62-4.72) incresed risk for developing IHD. The prevlence of ischemic ECG nd odds rtios (OR) for IHD of the middle-ged mle workers in Tiwn, strtified ccording to overweight nd ftty liver sttus, re presented in Tble 4. The prevlence of ischemic ECG nd the risk for IHD of the ftty liver-ffected subjects with or without overweight nd the overweight subjects free from ftty liver ws 30.1%, OR: 2.95 (95% CI: 2.31-4.09), 19.1%, OR:1.60 (95% CI: 1.07-2.39) nd 14.4%, OR: 1.11 (95% CI: 0.78-1.56), respectively, compred to the subjects without ftty liver nor overweight. Result of test for interction between ftty liver nd overweight ws significnt (P<0.05). DISCUSSION Stress test or even coronry ctheteriztion exmintion nturlly hs better specificitiy in IHD dignosis, nd biopsy of liver is the gold stndrd for heptostetosis. However, in the viewpoints of sfety, ethic nd screening purpose, resting ECG nd bdominl sonogrphic exmintion hve cceptble relibility nd re prcticl tools of epidemiologicl survey [10,16-18,21]. Our study indictes tht dult mle workers with ftty liver re more likely to develop IHD compred to subjects Tble 3 Multivrite logistic regression nlysis for the risk fctors for IHD Risk fctors Odds rtio 95% CI Age (yr) 0.99 0.97-1.00 Systolic blood pressure 1.01 1.003-1.03 Distolic blood pressure 0.99 0.97-1.01 Fsting sugr 1.00 1.00-1.006 Cholesterol totl 0.99 0.98-1.007 Cholesterol HDL 1.01 1.00-1.03 Cholesterol LDL 1.01 0.99-1.02 Triglyceride 1.00 1.00-1.003 Overweight 1.32 1.01-1.73 Ftty liver b Mild ftty liver 1.88 1.37-2.60 Moderte ftty liver 2.37 1.66-3.37 Severe ftty liver 2.76 d 1.62-4.72 Smoking 0.85 0.65-1.10 Alcohol consumption 1.054 0.79-1.41 P<0.05 vs Non FL group; b P<0.001 vs Non FL group; d P <0.0001 vs Non FL group. without ftty liver. This finding is comptible to previous studies demonstrting tht ftty liver, s developer of oxidtive stress plys crdinl role in crdic dysfunction [24,25]. Of prticulr significnce is the fct tht non-overweight subjects with ftty liver experience significntly incresed IHD risk (OR: 1.6). As Prk et l. [26], concluded, for non-obese men with ftty liver, systemic inflmmtory response increses, nd systemic inflmmtory response is the integrl prt of the therosclerotic process [27,28]. IHD prevention for nonoverweight subjects hving ftty liver should be emphsized in clinicl prctice. Findings of this study show synergistic interction between ftty liver nd overweight, this combintion mkes middle-ged mles hve significntly highest IHD risk (OR: 2.95) in the four entities (Tble 4). Similr findings hve been shown in studies bout insulin resistnce [7,10,26,29-31], these studies mnifested tht both overweight nd ftty liver re closely correlted with insulin resistnce, which ggrvtes the therogenic metbolic process [32,33], ccelerting the development of therosclerosis [34] nd IHD [35]. For overweight middle-ged mle workers with ftty liver, comprehensive mngement for IHD risk reduction is needed. Serum sugr nd lipids hd insignificnt effects on developing IHD in this study, these findings re similr to our previous study bsed on Estern popultion [36]. Genetic differences [37] nd differences in diet components [38] my hve ffected these findings. Smoking nd drinking did not show significnt effects on developing IHD in this study, the prtil explntion Tble 4 Odds rtio for IHD strtified ccording to ftty liver (FL) nd overweight sttus Non-overweight (n = 1 186) Overweight (n = 839) Non-FL FL Non-FL FL (n = 970) (n = 216) (n = 458) (n = 381) Ischemic ECG (%) 125 (12.9) 41 (19.1) 66 (14.4) 115 (30.1) 1 OR (95%CI) 1.0 (-) 1.60 c (1.07-2.39) 1.11 (0.78-1.56) 2.95 b (2.31-4.09) P<0.05 vs overweight nd ftty, djusted for ge, blood pressure, blood sugr nd lipid profile; b P<0.001 vs non-overweight nd non-fl group; c P<0.05 vs non-overweight nd non-fl group; 1 OR: djusted odds rtio; CI: confidence intervl.
Lin YC et l. Ftty liver reltes to ischemic hert disese 4841 might be tht binry questionnire could provide only limited informtion bout the dose-effect, which is importnt in the development of IHD, nd then leds to the unstedy results [36,39]. The findings of this study demonstrte tht ftty liver is n independent risk fctor for IHD. Abdominl sonogrphic exmintion my not only provide limited report bout the liver sttus, but lso cn provide vluble informtion for IHD risk ssessment, especilly for those who re overweight. ACKNOWLEDGMENTS The uthors would like to cknowledge the personnel of the Deprtment of Fmily Medicine nd Internl Medicine, Shin Kong Wu Ho-Su Memoril Hospitl for their full support nd generous ssistnce. REFERENCES 1 Akhoshi M, Amski Y, Sod M, Toming T, Ichimru S, Nkshim E, Seto S, Yno K. Correltion between ftty liver nd coronry risk fctors: popultion study of elderly men nd women in Ngski, Jpn. Hypertens Res 2001; 24: 337-343 2 Angelico F, Del Ben M, Conti R, Frncioso S, Feole K, Mccioni D, Antonini TM, Alessndri C. Non-lcoholic ftty liver syndrome: heptic consequence of common metbolic diseses. J Gstroenterol Heptol 2003;18: 588-594 3 Knobler H, Schttner A, Zhornicki T, Mlnick SD, Keter D, Sokolovsky N, Lurie Y, Bss DD. Ftty liver-n dditionl nd tretble feture of the insulin resistnce syndrome. QJM 1999; 92: 73-79 4 Chilton RJ. Recent discoveries in ssessment of coronry hert disese: impct of vsculr mechnisms on development of therosclerosis. J Am Osteopth Assoc 2001; 101: S1-5 5 Gnz P, Creger MA, Fng JC, McConnell MV, Lee RT, Libby P, Selwyn AP. Pthogenic mechnisms of therosclerosis: effect of lipid lowering on the biology of therosclerosis. Am J Med 1996; 101(4A): 10S-16S 6 Bonor E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bondonn RC, Muggeo M. Bruneck study. Crotid therosclerosis nd coronry hert disese in the metbolic syndrome: prospective dt from the Bruneck study. Dibetes Cre 2003; 26: 1251-1257 7 Indulski JA, Lutz W. Ischemic hert disese s n effect of obesity-relted metbolic disturbnces. Cent Eur J Public Helth 1999; 7: 122-129 8 Jeppesen J, Hein HO, Sudicni P, Gyntelberg F. High triglycerides/low high-density lipoprotein cholesterol, ischemic electrocrdiogrm chnges, nd risk of ischemic hert disese. Am Hert J 2003; 145: 103-108 9 Lmrche B, Despres JP, Moorjni S, Cntin B, Dgenis GR, Lupien PJ. Triglycerides nd HDL-cholesterol s risk fctors for ischemic hert disese. Results from the Quebec crdiovsculr study. Atherosclerosis 1996; 119: 235-245 10 Hsio TJ, Chen JC, Wng JD. Insulin resistnce nd ferritin s mjor determinnts of nonlcoholic ftty liver disese in pprently helthy obese ptients. Int J Obesity 2004; 28: 167-172 11 Li SW, Tn CK, Ng KC. Epidemiology of ftty liver in hospitl-bsed study in Tiwn. Southern Med J 2002; 95: 1288-1292 12 Chen CH, Chung JH, Kuo HS, Chng MS, Wng SP, Chou P. Prevlence of coronry hert disese in Kin-Chen, Kinmen. Int J Crdiol 1996; 55: 87-95 13 Leung KW, Liu JD, Chen PH, Wng CS, Wng CK, Hung MJ, Siuw CP, Yun CY, Chen TY. Clinicl significnce nd dignosis of ftty liver in Tiwn. Tiwn i Hsueh Hui Ts Chih. J Formos Med Assoc 1986; 85: 149-160 14 Lu SN, Wng LY, Chng WY, Chen CJ, Su WP, Chen SC, Chung WL, Hsieh MY. Abdominl sonogrphic screening in single community. Kohsiung J Med Sci 1990; 6: 643-646 15 Yng PM, Hung GT, Lin JT, Sheu JC, Li MY, Su IJ, Hsu HC, Chen DS, Wng TH, Sung JL. Ultrsonogrphy in the dignosis of benign diffuse prenchyml liver diseses: prospective study. J Formos Med Assoc 1988; 87: 966-977 16 Hmpton JR. The importnce of minor bnormlities in the resting electrocrdiogrm. Eur Hert J 1984; 5 (Suppl A): 61-63 17 Okin PM, Devereux RB, Kors JA, vn Herpen G, Crow RS, Fbsitz RR, Howrd BV. Computerized ST depression nlysis improves prediction of ll-cuse nd crdiovsculr mortlity: the strong hert study. Annls Noninvsive Electrocrdiol 2001; 6: 107-116 18 Knnel WB, Anderson K, McGee DL, Degtno LS, Stmpfer MJ. Nonspecific electrocrdiogrphic bnormlity s predictor of coronry hert disese: the Frminghm Study. Am Hert J 1987; 113: 370-376 19 Anonymous. Obesity: preventing nd mnging the globl epidemic. Report of WHO consulttion. WHO Technicl Report Series 2000; 894: 1-253 20 Sdeh S, Younossi ZM, Remer EM, Grmlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridn MJ. The utility of rdiologicl imging in nonlcoholic ftty liver disese. Gstroenterology 2002; 123: 745-750 21 Steinmurer HJ, Jirk P, Wlchshofer J, Clodi PH. Accurcy of sonogrphy in the dignosis of diffuse liver prenchyml diseses-comprison of sonogrphy nd liver histology. Ultrschll Der Medizin 1984; 5: 98-103 22 Tm KM, Wu JS. Ultrsonogrphic dignosis of ftty liver. J Formos Med Assoc 1986; 85: 45-53 23 Yjim Y, Oht K, Nrui T, Abe R, Suzuki H, Ohtsuki M. Ultrsonogrphicl dignosis of ftty liver: significnce of the liver-kidney contrst. Tohoku J Exp Med 1983; 139: 43-50 24 Videl LA, Rodrigo R, Orelln M, Fernndez V, Tpi G, Quinones L, Vrel N, Contrers J, Lzrte R, Csendes A, Rojs J, Mluend F, Burdiles P, Diz JC, Smok G, Thielemnn L, Ponichik J. Oxidtive stress-relted prmeters in the liver of non-lcoholic ftty liver disese ptients. Clin Sci 2004; 106: 261-268 25 Koenig W. Hert disese nd the inflmmtory response. BMJ 2000: 321: 187-188 26 Prk SH, Kim BI, Yun JW, Kim JW, Prk DI, Cho YK, Sung IK, Prk CY, Sohn CI, Jeon WK, Kim H, Rhee EJ, Lee WY, Kim SW. Insulin resistnce nd C-rective protein s independent risk fctors for non-lcoholic ftty liver disese in non-obese Asin men. J Gstroenterol Heptol 2004; 19: 694-698 27 Bndyopdhyy D, Chttopdhyy A, Ghosh G, Dtt AG. Oxidtive stress-induced ischemic hert disese: protection by ntioxidnts. Curr Med Chem 2004; 11: 369-387 28 Rothenbcher D, Hoffmeister A, Brenner H, Koenig W. Physicl ctivity, coronry hert disese, nd inflmmtory response. Arch Intern Med 2003; 163: 1200-1205 29 Goto T, Onum T, Tkebe K, Krl JG. The influence of ftty liver on insulin clernce nd insulin resistnce in non-dibetic Jpnese subjects. Int J Obesity 1995; 19: 841-845 30 Strng BD, Bertics SJ, Grummer RR, Armentno LE. Reltionship of triglyceride ccumultion to insulin clernce nd hormonl responsiveness in bovine heptocytes. J Diry Sci 1998; 81: 740-747 31 Grundy SM. Metbolic complictions of obesity. Endocrine 2000; 13: 155-165 32 Cohn G, Vldes G, Cpuzzi DM. Pthophysiology nd tretment of the dyslipidemi of insulin resistnce. Current Crdiol Rep 2001; 3: 416-423 33 Grg A. Insulin resistnce in the pthogenesis of dyslipidemi. Dibetes Cre 1996; 19: 387-389 34 Dndon P. Insulin resistnce nd endothelil dysfunction in
4842 ISSN 1007-9327 CN 14-1219/ R World J Gstroenterol August 21, 2005 Volume 11 Number 31 therosclerosis: implictions nd interventions. Dibetes Technol Ther 2002; 4: 809-815 35 Lmrche B, Tchernof A, Muriege P, Cntin B, Dgenis GR, Lupien PJ, Despres JP. Fsting insulin nd polipoprotein B levels nd low-density lipoprotein prticle size s risk fctors for ischemic hert disese. JAMA 1998; 279: 1955-1961 36 Lin YC, Chu FY, Fu CC, Chen JD. Prevlence nd risk fctors for ngin in elderly Tiwnese. J Gerontol A Biol 2004; 59: 161-165 37 Mitchell BD, Hzud HP, Hffner SM, Ptterson JK, Stern MP. High prevlence of ngin pectoris in Mexicn-Americn men. A popultion with reduced risk of myocrdil infrction. Ann Epidemiol 1991; 1: 415-426 38 Burchfiel CM, Abbott RD, Shrp DS, Curb JD, Rodriguez BL, Yno K. Distribution nd correltes of lipids nd lipoproteins in elderly Jpnese-Americn men. The Honolulu Hert Progrm. Arterioscler Thromb Vsc Biol 1996; 16: 1356-1364 39 Gzino JM, Buring JE, Breslow JL, Goldhber SZ, Rosner B, Vn Denburgh M, Willett W, Hennekens CH. Moderte lcohol intke, incresed levels of high-density lipoprotein nd its subfrctions, nd decresed risk of myocrdil infrction. New Eng J Med 1993; 329: 1829-1834 Science Editor Wng XL nd Guo SY Lnguge Editor Elsevier HK